Alternate Health Corp (CSE:AHG) (OTC:AHGIF), is a diverse healthcare company revolutionizing patient care and research through compliance and technology in the emerging medical cannabis industry. The time to ...
TORONTO, June 6, 2017 /CNW/ - Alternate Health Corp (CSE:AHG) (OTC:AHGIF), a diverse healthcare company revolutionizing patient care and research through compliance and technology in the emerging medical cannabis industry, is delighted to announce the upcoming launch of a new clinical study on the effects of Cannabidiol (CBD) in the treatment of veterans suffering from Post-Traumatic Stress Disorder (PTSD). Veterans' activist, Wesley Clark Jr., who himself served in the US Military, will lead the study beginning in June 2017.
"Cannabis is the treatment for PTSD," says Wesley Clark Jr., leader of the initiative. "This study will finally demonstrate irrefutable evidence, forcing the FDA to make a change for the better."
Alternate Health will conduct the PTSD study at its newly acquired Neubauer Center in Lauderdale-By-The-Sea, Florida, with the help of veterans suffering the effects of PTSD. The study will research the results of CBD administered through Alternate Health's delivery systems technology, building on the company's research assets. The company expects the results to bolster support and awareness of CBD in the medical community, with possible scientific breakthroughs forming the potential basis of new technology and patents.
"It is unquestionable that veterans receive comfort and relief from cannabis and CBD," adds Wesley Clark Jr. "We want to demonstrate the effectiveness of cannabis and CBDs, while exploring Alternate Health's patented delivery systems of sublingual dissolvable tablets and time release transdermal patches as a method of treatment."
Wesley Clark Jr.'s father, General Wesley Clark joined Alternate Health's Board of Directors in April 2017. A retired U.S. Army General and NATO Commander, General Clark shares his son's advocacy for veterans' health, from acute injuries to psychological trauma.
"Throughout my son's career, he has always been a strong proponent of veterans' rights and the anecdotal evidence of the treatment of PTSD with cannabis," says General Wesley Clark Sr. "We both look forward to corroborating this evidence with hard science."
Alternate Health and the Neubaurer Center previously collaborated on the successful Zika Virus Symptom Study, researching the use of CBD in treating patients suffering from the chronic effects of post-viral infection.
"Through this study, Alternate Health has the opportunity for substantial contribution to those who suffer from PTSD. We are honored to provide support for our Veterans and are eager to apply and study what we have learned about CBDs in other fields of medicine toward treating PTSD," says Dr. Jamison Feramisco, CEO Alternate Health.
About Wesley Clark Jr.
Wes was born in Jacksonville, Florida while his dad was in Vietnam. He spent four years in the military himself, and now resides in Los Angeles, California where he works as a screenwriter, and occasionally guest hosts on The Young Turks progressive internet show.
About Alternate Health Corp.
Alternate Health Corp. is a technology-focused healthcare company, driving innovation in complementary medicine, clinical research and medical cannabis. Based on a portfolio of clinical laboratories, research studies and medical software, Alternate Health invests in research, testing and production for the medicinal and therapeutic use of Cannabidiol (CBD) and other cannabinoids. Leveraging the company's assets in exclusive patents and partnerships, Alternate Health positions itself to be the global authority on the science, manufacturing and administration of medical cannabis.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations, business prospects and financing plans, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward looking statements
SOURCE Alternate Health Corp.
For further information: Mike English, 972-378-3796, firstname.lastname@example.org